| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Protein |
| Molecule Category: | UNKNOWN |
| UNII: | A67JUW790C |
| InChI Key | OIDGWOIMPADMGM-GXSWRUKYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C145H232N40O43S |
| Molecular Weight | 3255.75 |
| AlogP | None |
| Hydrogen Bond Acceptor | None |
| Hydrogen Bond Donor | None |
| Number of Rotational Bond | None |
| Polar Surface Area | None |
| Molecular species | None |
| Aromatic Rings | None |
| Heavy Atoms | None |
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | Adrenergic receptor alpha antagonist |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Membrane receptor
Family B G protein-coupled receptor
Peptide receptor (family B GPCR)
Vasoactive intestinal peptide receptor
Vasoactive intestinal peptide receptor
|
0.19 | - | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
| Acute Lung Injury | 2 | D055371 | ClinicalTrials |
| Respiratory Distress Syndrome | 2 | D012128 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2106041 |
| DrugBank | DB06260 |
| FDA SRS | A67JUW790C |
| PubChem | 70691420 |